Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : International Nursing Services Inc, old (NURS) new (MDIX) -- Ignore unavailable to you. Want to Upgrade?

To: peter michaelson who wrote (714)	4/28/1998 10:57:00 AM
From: Instock	Respond to of 2911

Is there a second News Story coming soon? IN

To: peter michaelson who wrote (714)	4/28/1998 12:53:00 PM
From: Sandra	Read Replies (2) \| Respond to of 2911

peter, Answers to your questions! Q1. MDIX has 12.8 million shares. Due to receive up to $9 million cash about $0.72 per share. A1. MDIX had 12.8 million shares before the Cymedix merger. There are now right at 20 million shares and the cash from the sale of the businesses is about $.43 per share. Q2. Now, what will be the taxation on this amount? Is there a substantial tax loss carryforward? I didn't see it on the 10-K, but I didn't spend a lot of time looking. A2. The company has substantial tax loss carry forwards as well as over $1 million in R&D credit from the Cymedix acquisition. The R&D use is a little limited due to the newer tax laws. The other losses will shelter profit for a long time. Q3. How much money will MDIX lose this year? A3. According to the announcement this morning, they expect the sale of the staffing business to close in September. Earlier this year the company expected to make about $750K. If the sale closes on time, MDIX should still show a small profit for the year in the $.04-$.08 area. Q4. How much do they need to get their balance sheet in better position? A4. I'm not sure what this question means. The company is going to end the year with over $6 million cash and $2 million market securities (senior stock). I'd like to have that balance sheet. Q5. How much is left over as free cash per share, if any? A5. The company has virtually no debt. Cymedix has no debt. Both companies have payables in line (the paydex for MDIX is 71). Almost all the cash received from the sale of its businesses can immediately be put to use in its Internet business. I would say that we are at bargain prices here, hope that answers all your questions. Sandra